Education
About Us
Working with TipRanks
Follow Us
Q-linea AB (SE:QLINEA)
:QLINEA
QLINEA Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr30.87 - kr986.15
Previous CloseN/A
Volume6.05M
Average Volume (3M)29.83K
Market Cap
kr323.75M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.64
Next Earnings
Oct 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.13
Shares Outstanding6,436,873
10 Day Avg. Volume26,534
30 Day Avg. Volume29,830
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Q-linea AB News
QLINEA FAQ
What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was kr30.87 and its highest was kr986.15 in the past 12 months.
What is Q-linea AB’s market cap?
Q-linea AB’s market cap is kr323.75M.
When is Q-linea AB’s upcoming earnings report date?
Q-linea AB’s upcoming earnings report date is Oct 30, 2025 which is in 91 days.
How were Q-linea AB’s earnings last quarter?
Q-linea AB released its earnings results on Jul 10, 2025. The company reported -kr9.13 earnings per share for the quarter, missing the consensus estimate of N/A by -kr9.13.
Is Q-linea AB overvalued?
According to Wall Street analysts Q-linea AB’s price is currently Overvalued.
Does Q-linea AB pay dividends?
Q-linea AB does not currently pay dividends.
What is Q-linea AB’s EPS estimate?
Q-linea AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q-linea AB have?
Q-linea AB has 6,436,873 shares outstanding.
What happened to Q-linea AB’s price movement after its last earnings report?
Q-linea AB reported an EPS of -kr9.13 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.955%.
Which hedge fund is a major shareholder of Q-linea AB?
Currently, no hedge funds are holding shares in SE:QLINEA
Company Description
Q-linea AB
Q-linea AB (QLINEA) is a Swedish-based biotechnology company that specializes in developing advanced diagnostic solutions for infectious diseases. The company's primary focus is on creating innovative and rapid diagnostic systems that can significantly improve patient care by enabling timely and precise diagnosis. Q-linea's flagship product is ASTar, an automated system designed for fast and reliable antimicrobial susceptibility testing, which helps healthcare providers make informed treatment decisions.
Technical Analysis
Acarix AB
―
Clinical Laserthermia Systems AB Class B
―
Luxbright AB
―
SciBase Holding AB
―
SpectraCure AB
―
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---